Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-034990
Filing Date
2009-06-29
Accepted
2009-06-29 17:28:00
Documents
7
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 v153293_10k.htm 10-K 3138793
2 GRAPHIC chart.jpg GRAPHIC 62119
3 v153293_ex21.htm EX-21 2155
4 v153293_ex31-1.htm EX-31.1 12573
5 v153293_ex31-2.htm EX-31.2 10292
6 v153293_ex32-1.htm EX-32.1 8946
7 v153293_ex32-2.htm EX-32.2 8289
  Complete submission text file 0001144204-09-034990.txt   3268156
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 09917300
SIC: 2834 Pharmaceutical Preparations